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Summary
We determined brain to liver weight ratio (BLWR) thresholds
for fetal growth restriction (FGR) using autopsy information on
395 perinatal deaths comprising stillborn babies who died
during labour and neonatal deaths. FGR was deﬁned using
two methods: (1) birth weight for gestational age (WGA) less
than the 10th percentile; and (2) WGA less than the 10th
percentile or discordant birth weight/length. The association
between BLWR and FGR was investigated using odds ratios,
and classiﬁcation statistics were calculated for a range of
BLWR thresholds. Using WGA, 84 cases (21.3%) were FGR
and a further 15 cases (n¼99, 25%) had discordant birth
weight/length. The BLWR ranged from 1.02 to 7.30 and was
positively associated with FGR. BLWR was not associated
with FGR for babies with congenital central nervous system
or chromosomal abnormalities. Excluding these, for FGR
deﬁned using WGA and discordant birth weight/length, a
BLWR threshold of 5.0 was 100% predictive of FGR. A BLWR
threshold of 3.0 for babies over 28 weeks gestation and 3.7 for
more preterm babies optimised case detection while mini-
mising missed and false positive cases. Additional evidence
of FGR should be sought for babies with a BLWR of less than
5.0 to conﬁrm FGR.
Key words: Autopsy standards, brain to liver weight ratio, fetal growth
restriction, perinatal death, small for gestational age.
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INTRODUCTION
Causes of pathological fetal growth restriction (FGR) are
diverse and include many factors such as uteroplacental insuf-
ficiency, chronic maternal diseases, congenital and genetic
disorders, infections and environmental conditions.1 Correctly
identifying FGR in perinatal deaths is important for under-
standing the clinical pathway that led to the death and the
existence of any preventable factors. A diagnosis of FGR in a
perinatal death is important information for clinicians and
families, and has implications for the management of sub-
sequent pregnancies.
Historically, FGR has been classified as either symmetrical
or asymmetrical. In symmetrical FGR, reduced fetal growth is
equally reflected across all developing organs and body parts
resulting in a small but proportionally shaped infant. In con-
trast, asymmetrical FGR refers to cases where the rate of
growth is unbalanced between different organs and body parts,
and where energy is preferentially redirected to vital organs
such as the brain and heart at the expense of other organs such
as the liver.2,3 Consequently, asymmetrical FGR infants are
characterised by disproportionate growth manifested as a low
birth weight but with relatively spared length and head
circumference.4
More recently, the classification of FGR has been expanded
to three main types.5 Type I is symmetrical FGR and is
characterised by decreased growth in early pregnancy due to
altered cell proliferation of the developing embryo. Type II
defines asymmetrical FGR, which is manifested later in preg-
nancy, generally after 30–32 weeks gestation, and is primarily
attributed to reduced cell size. Type III cases of FGR are
instances where growth restriction occurs due to a combination
of reduced cell proliferation and growth and is a mixture of
Type I and Type II FGR. The onset of Type III FGR occurs
during the second trimester, the period in which cells are still
undergoing proliferation while also starting to increase in size.
FGR represents the failure of babies to reach their genetically
determined growth potentials,1 and is associated with an
increased risk of mortality and morbidity.1,6,7 Diagnosis of
FGR is commonly based on the comparison of estimated fetal
weight to population-based standards and is usually defined as a
birth weight for gestational age (WGA) below the 10th per-
centile.8,9 However, difficulties arise in using birth weight
percentiles to diagnose FGR in stillborn babies due to the
maceration that follows death in utero and the lack of certainty
about the gestational age at death.10 Additional information that
may be used to assess FGR in and ex utero include fundal height
measurements, head circumference to abdominal circumfer-
ence ratio, femur length to abdominal circumference ratio,
amniotic fluid index, maternal arterial umbilical blood flow,
placental grading,1,8,9 thigh wasting and brain to liver weight
ratio (BLWR) based on information obtained at post-mortem
examination.11,12
An increase in BLWR is the result of unbalanced fetal
growth in response to stress, where the growth of the brain
and other key organs such as the heart are ‘spared’ at the
expense of other, less vital organs such as the liver, kidneys,
pancreas and skeletal muscle.13,14 Several studies have inves-
tigated the relationship between brain to liver weight (or
volume) ratios and FGR.11,12,15 Anderson assessed BLWR in
fresh stillborn and neonatal deaths using weights obtained from
autopsy reports, and found the mean BLWR of infants that
displayed normal body weight was 2.8 and that a ratio greater
than 4.5 was a strong indicator of dysmature babies with low
body weight.11 Mitchell investigated using the BLWR to
predict low body weight in stillborn babies, using a birth weight
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less than the 10th percentile to classify babies as FGR. Mitchell
found that the BLWR tended to be elevated in FGR babies;
however, the BLWR alone was considered unlikely to be an
adequate indicator of FGR due to poor sensitivity and speci-
ficity.12 Boito et al. utilised ultrasound technology to estimate
brain and liver volumes in a series of pregnancies, and found
that developing fetuses that were subsequently classified as
FGR at birth displayed a marked elevation in volume ratios at
the time of sonographic examination.15
The aim of this study is to determine BLWR thresholds for
FGR at autopsy in a normative population of perinatal deaths,
comprising stillborn babies who died during labour or in the
neonatal period in New South Wales (NSW), Australia.
MATERIALS AND METHODS
The study population included all singleton stillborn babies that died during
labour and neonatal deaths that were reported to the NSW Ministry of Health
from 2000 to 2012 and had post-mortem information on brain and liver weights
available. Of the 9364 perinatal deaths in 2000 to 2012 that were reported to the
NSWMinistry of Health at the time the study commenced, 3007 were singleton
neonatal deaths or stillbirths that died during labour. Of these 3007 deaths, a
post-mortem had been carried out on 763. The study population comprised 395
deaths for which complete information on birth weight, gestational age and brain
and liver weights was available.
Confidential reviews of perinatal deaths are carried out by the NSWMaternal
and Perinatal Committee, which is appointed by the Minister for Health to
review maternal and perinatal morbidity and mortality in NSW. Obstetric cause-
specific death classifications for stillbirths and neonatal deaths are assigned
according to the Perinatal Society of Australia and New Zealand Perinatal Death
Classification and Neonatal Death Classification.16 Stillbirth is defined as:
‘Death prior to the complete expulsion or extraction from its mother of a
product of conception of 20 or more completed weeks of gestation or of 400 g or
more birth weight where gestation is not known. The death is indicated by the
fact that after such separation the fetus does not breathe or show any other
evidence of life, such as beating of the heart, pulsation of the umbilical cord,
or definite movement of voluntary muscles.’16 Neonatal death is defined as
the death of a live-born baby within 28 days of life.
FGR was defined in two ways:
1. Birth WGA below the 10th percentile. This was assessed using Australian
birth weight percentile standards.17
2. Birth WGA below the 10th percentile or birth weight and length
discordance. As with the ﬁrst approach, WGA below the 10th percentile
was assessed using Australian birth weight percentile standards.17 Birth
weight and length discordance was assessed using expected gestational ages
based on the baby’s birth weight and length, obtained from Australian 50th
percentile standards.17,18 Babies were deﬁned as FGR when the expected
gestational age for length was at least 4 weeks greater than the expected
gestational age for weight, or the birth WGAwas below the 10th percentile.
The use of a difference of four weeks or more in expected gestational ages to
indicate FGR is based on Australian birth weight percentile standards,17
which show that the 10th percentile birth weight for a given gestation
corresponds to the 50th percentile birth weight for the gestation
2–4 weeks earlier.
Characteristics of FGR and non-FGR cases for both definitions were
compared. Logistic regression was used to calculate the odds ratio (OR) for
the association between the BLWR (continuous) and FGR, and to investigate
variation by the presence/absence of congenital conditions for both definitions
of FGR. To compare the definitions of FGR and investigate the performance of
selected BLWR thresholds, 2 by 2 classification tables were constructed by
cross-tabulating FGR and a dichotomised BLWR variable where values above
the threshold were classified as FGR and those below as non-FGR. BLWR
thresholds of interest (2.8, 3.0, 3.5, 4.0, 4.5 and 5.0) were selected a priori to
provide a range of values based on those previously reported in the literature and
considered clinically relevant. For the selected BLWR thresholds, the following
classification statistics and their exact binomial 95% confidence intervals were
calculated:
1. Sensitivity: percentage of true FGR cases classiﬁed as FGR.
2. Speciﬁcity: percentage of true non-FGR cases classiﬁed as non-FGR.
3. Positive predictive value (PPV): percentage of cases classiﬁed as FGR that
are true FGR.
4. Negative predictive value (NPV): percentage of cases classiﬁed as non-FGR
that are true non-FGR.
An optimal BLWR threshold was also calculated using Youden’s index,19 a
measure of overall diagnostic effectiveness that balances the trade-off between
sensitivity and specificity. Finally, counts of true positive, true negative, false
positive and false negative cases for the study population were obtained by
comparing the classification of babies as FGR by selected BLWR thresholds and
WGA below the 10th percentile or birth weight/length discordance. Data
manipulation and statistical analyses were carried out using SAS Enterprise
Guide 5.1 and R 2.15.1.20,21
This study used data collected by the NSW Maternal and Perinatal Com-
mittee, which is a quality assurance committee established under the NSW
Health Administration Act 1982. As the study conformed to the standards
established by the National Health and Medical Research Council for ethical
quality review,22 ethics committee approval was not necessary.
RESULTS
The study population of 395 deaths comprised 135 stillbirths and
260neonatal deaths.Of these 395 babies, 38.5%had a congenital
condition, 68.1% were low birth weight (less than 2500 g) and
53.4% were extremely preterm (less than 28 weeks gestation).
The BLWR ranged from 1.02 to 7.30 (Table 1).
Using WGA less than the 10th percentile, 84 (21.3%) babies
were defined as FGR, with higher proportions of FGR cases
observed in babies with congenital conditions (25.0%), of low
birth weight (23.0%), 28 weeks gestation or greater (28.3%),
higher BLWR quintiles (3.56–7.30; 45.6%) and birth length
less than or equal to the 10th percentile (69.8%). The addition
of birth weight/length for gestational age discordance to the
WGA definition of FGR identified an extra 15 cases, increasing
the total to 99 (25.1%). Comparatively, this led to increases in
the proportion of FGR cases observed in babies with a birth
weight of 2500 g or more from 17.5% to 28.6%, babies of
28 weeks gestation or greater from 28.3% to 35.9%, and babies
with a birth length above the 90th percentile from 3.1% to
18.8% (Table 1).
The study population included 152 babies with congenital
conditions of which 25.7% were affected by conditions of the
central nervous system (CNS) or had chromosomal anomalies
(CA) (Table 1). For the definition of FGR based onWGA only,
logistic regression demonstrated that the association between
FGR and the BLWR was strongest for babies without con-
genital conditions (OR 3.3) and without CNS conditions or CA
(OR 2.9) (Fig. 1). The association between FGR and the BLWR
was weaker when all babies were considered (OR 2.2) and
further reduced for babies with congenital conditions (OR 1.5).
The association was in the opposite direction for the subgroup
of babies with CNS or CA congenital conditions (OR 0.5),
although not significantly so. Similar estimates of association
were found when using FGR defined with the addition of birth
weight/length discordance. CNS conditions and CA therefore
were excluded from subsequent analyses.
Sensitivity and PPV for selected BLWR thresholds were
very similar for both FGR definitions, with WGA having
slightly better sensitivity and the addition of birth weight/length
discordance providing a slight increase in PPV (Fig. 2). Higher
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sensitivitywas observed at lowerBLWR thresholds,with a value
of 64.4% at BLWR of 2.8 using the second definition of FGR
which also had the highest PPV of 100% at a threshold of 5.0.
As the addition of discordant birth weight/length for gesta-
tional age to the definition of FGR added only one case of FGR
less than 28 weeks gestation compared to 14 cases of 28-plus
weeks gestation, subsequent analysis was also stratified by
gestational age (Table 2). This revealed a shift from a weaker
association between FGR and the BLWR at lower thresholds to
a stronger association at higher thresholds for the less the
Table 1 Characteristics of the study population by FGR status for two deﬁnitions of FGR
Variable/category
FGR (WGA <10th percentile) FGR (plus discordance)* Total
No Yes FGR{ Cases added FGR{
n n % n % n %
Congenital condition
No 197 46 18.9 12 23.9 243 61.5
Yes
All 114 38 25.0 3 27.0 152 38.5
CNS or CAz 31 8 20.5 1 23.1 39 25.7
Gender
Male 186 48 20.5 7 23.5 234 59.2
Female 125 36 22.4 8 27.3 161 40.8
Perinatal death
Stillbirth 109 26 19.3 5 23.0 135 34.2
Neonatal 202 58 22.3 10 26.2 260 65.8
Gestational age, weeks
<28 179 32 15.2 1 15.6 211 53.4
28þ 132 52 28.3 14 35.9 184 46.6
Birth weight, g
<2500 207 62 23.0 1 23.4 269 68.1
2500þ 104 22 17.5 14 28.6 126 31.9
Brain to liver weight ratio quintiles
1.02–2.07 69 10 12.7 1 13.9 79 20.0
2.07–2.56 70 9 11.4 3 15.2 79 20.0
2.56–2.96 66 13 16.5 4 21.5 79 20.0
2.96–3.56 63 16 20.3 4 25.3 79 20.0
3.56–7.30 43 36 45.6 3 49.4 79 20.0
Birth length percentiles
<3 5 22 81.5 0 81.5 27 8.5
3–10 11 15 57.7 0 57.7 26 8.2
10–50 83 25 23.1 0 23.1 108 34.0
50–90 115 10 8.0 10 16.0 125 39.3
90–97 18 1 5.3 3 21.1 19 6.0
>97 13 0 0.0 2 15.4 13 4.1
Total 311 84 21.3 15 25.1 395 100.0
FGR, fetal growth restriction; WGA, weight for gestational age.
* FGR deﬁned as WGA <10th percentile or weight/length discordance.
{Denotes percentage of strata group that is FGR.
zCNS or CA: central nervous system conditions or chromosomal anomalies, which are a subset of all congenital conditions.
All cases
Congenital conditions
CNS or CA congenital conditions
Congenital conditions (CNS  and CA removed) 
All congenital conditions removed 
CNS and CA congenital conditions removed
0 1 2 3 4 5 6
odds ratio
FGR definition
WGA < 10th percentile
WGA < 10th percentile or weight/length discordant
Fig. 1 Effect of congenital conditions on the association between the BLWR and FGR by deﬁnition of FGR. BLWR, brain to liver weight ratio; CNS or CA, central
nervous system conditions or chromosomal anomalies; FGR, fetal growth restriction; WGA, weight for gestational age. Bars represent 95% conﬁdence intervals.
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Table 2 Odds ratios and classiﬁcation statistics for various BLWR thresholds by gestational age*
Group (FGR{ cases) BLWR OR 95% CI SN (%) 95% CI SP (%) 95% CI NPV (%) 95% CI PPV (%) 95% CI
All ages (n¼ 90) 2.8 2.9 (1.7–4.7) 64.4 (53.7–74.3) 61.3 (55.1–67.2) 83.6 (77.6–88.5) 36.0 (28.6–44.0)
3.0 4.0 (2.4–6.7) 60.0 (49.1–70.2) 72.9 (67.2–78.2) 84.3 (79.0–88.8) 42.9 (34.1–52.0)
3.5 6.1 (3.5–10.6) 44.4 (34.0–55.3) 88.3 (83.9–91.9) 82.5 (77.5–86.7) 56.3 (44.0–68.1)
4.0 12.2 (5.6–26.3) 32.2 (22.8–42.9) 96.2 (93.2–98.2) 80.8 (76.0–84.9) 74.4 (57.9–87.0)
4.5 25.0 (7.2–86.7) 22.2 (14.1–32.2) 98.9 (96.7–99.8) 79.0 (74.2–83.2) 87.0 (66.4–97.2)
5.0z – – 20.0 (12.3–29.8) 100.0 (98.6–100.0) 78.7 (73.9–82.9) 100.0 (81.5–100.0)
3.3§ 5.4 (3.2–9.2) 51.1 (40.3–61.8) 83.8 (78.8–88.0) 83.5 (78.5–87.8) 51.7 (40.8–62.4)
<28 weeks gestation 2.8 2.1 (0.9–4.9) 60.7 (40.6–78.5) 58.2 (49.9–66.1) 89.0 (81.2–94.4) 21.0 (12.7–31.5)
(n¼ 28) 3.0 3.5 (1.5–8.0) 60.7 (40.6–78.5) 69.3 (61.3–76.5) 90.6 (83.8–95.2) 26.6 (16.3–39.1)
3.5 8.9 (3.7–21.5) 57.1 (37.2–75.5) 86.9 (80.5–91.8) 91.7 (86.0–95.7) 44.4 (27.9–61.9)
4.0 18.1 (6.3–52.3) 46.4 (27.5–66.1) 95.4 (90.8–98.1) 90.7 (85.1–94.7) 65.0 (40.8–84.6)
4.5 35.8 (7.2–178.0) 32.1 (15.9–52.4) 98.7 (95.4–99.8) 88.8 (83.1–93.1) 81.8 (48.2–97.7)
5.0z – – 28.6 (13.2–48.7) 100.0 (97.6–100.0) 88.4 (82.7–92.8) 100.0 (63.1–100.0)
3.7§ 13.2 (5.2–33.5) 57.1 (37.2–75.5) 90.8 (85.1–94.9) 92.1 (86.5–95.8) 53.3 (34.3–71.7)
28 weeks gestation 2.8 3.7 (1.9–7.1) 66.1 (53.0–77.7) 65.5 (56.0–74.2) 77.9 (68.2–85.8) 51.3 (39.8–62.6)
(n¼ 62) 3.0 5.2 (2.7–10.2) 59.7 (46.4–71.9) 77.9 (69.1–85.1) 77.9 (69.1–85.1) 59.7 (46.4–71.9)
3.5 5.9 (2.6–13.1) 38.7 (26.6–51.9) 90.3 (83.2–95.0) 72.9 (64.7–80.0) 68.6 (50.7–83.1)
4.0 12.8 (3.5–45.9) 25.8 (15.5–38.5) 97.3 (92.4–99.4) 70.5 (62.7–77.5) 84.2 (60.4–96.6)
4.5 24.2 (3.0–192.2) 17.7 (9.2–29.5) 99.1 (95.2–100.0) 68.7 (61.0–75.7) 91.7 (61.5–99.8)
5.0z – – 16.1 (8.0–27.7) 100.0 (96.8–100.0) 68.5 (60.8–75.5) 100.0 (69.2–100.0)
3.0§ 5.2 (2.7–10.2) 59.7 (46.4–71.9) 77.9 (69.1–85.1) 77.9 (69.1–85.1) 59.7 (46.4–71.9)
BLWR, brain to liver weight ratio; CI, conﬁdence interval; FGR, fetal growth restriction; NPV, negative predictive value; OR, odds ratio; PPV, positive predictive value;
SN, sensitivity; SP, speciﬁcity.
* Excludes central nervous system conditions or chromosomal anomalies.
{Deﬁned using weight for gestational age <10th percentile or discordant birth weight/length.
zOdds ratio calculation not possible as positive predictive grouping consists entirely of true positive cases and the denominator for odds calculation is zero.
§Optimal BLWR for classifying FGR based on Youden’s index.
WGA < 10th percentile
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Fig. 2 Sensitivity and positive predictive value for selected BLWR thresholds by FGR deﬁnition. BLWR, brain to liver weight ratio; FGR, fetal growth restriction;
WGA, weight for gestational age. Bars represent 95% conﬁdence intervals.
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28 weeks gestational age group compared to babies of 28-plus
weeks gestation. The highest sensitivity was found in the older
gestational age group (66.1% at a BLWR threshold of 2.8) while
in both groups PPV was 100% at a BLWR threshold of 5.0.
Sensitivity declinedmore rapidly with an increasing threshold in
the older gestational age group, while the PPV was poorer at
lower thresholds in the less than28weekgroup. For all thresholds
the less than 28 week group showed higher NPV, while the older
gestational age group showed higher specificity.
Using the second definition of FGR and applying Youden’s
index, the optimal BLWR threshold for all gestational ages was
determined to be 3.3 (Table 2). For babies less than 28 weeks
gestation, the optimal threshold was 3.7, while for babies of 28
weeks gestation or greater the optimal threshold was slightly
lower at 3.0. Stratifying by gestational age increased the
sensitivity and PPV of the optimal BLWR thresholds in both
groups compared to all gestational ages, while specificity and
NPV improved only for the less than 28 week group.
Using FGR defined as WGA below the 10th percentile or
weight/length discordance and excluding CNS conditions or
CA, Table 3 shows the study population separated into true
positive and negative and false positive and negative groups for
selected BLWR thresholds. Overall, a BLWR threshold of
5.0 detected only 18 cases of FGR with no false positive cases,
but missed 72 cases of FGR; while a BLWR of 2.8 correctly
detected more cases of FGR (n¼ 58), but incorrectly classified
103 non-FGR cases as FGR. The optimal threshold of 3.3
resulted in 46 FGR cases and 223 non-FGR cases correctly
classified, with 43 cases incorrectly classified as FGR (false
positive) and 44 cases incorrectly classified as non-FGR (false
negative). When optimal thresholds were applied by gestational
age, an additional seven cases were correctly classified as
FGR and an additional four cases correctly classified as non-
FGR, with fewer false positives and false negatives (4 and 7,
respectively).
DISCUSSION
We used information on birth weight and length obtained at
post-mortem examination for 395 perinatal deaths in NSW to
ascertain a threshold of BLWR that could be used to determine
FGR. We assessed the BLWR against two definitions of FGR:
first, WGA below the 10th percentile; and second, to improve
prediction, WGA below the 10th percentile or birth weight/
length discordance. Overall, we found that the BLWR was
positively associated with both definitions of FGR. However, in
the subset of babies with congenital conditions of the CNS or
with CA, BLWR was not associated with FGR, indicating that
FGR in these babies does not differentially spare the brain—a
finding that is clinically intuitive. Babies with conditions of
the CNS or with CA were subsequently excluded from the
analysis.
The second definition of FGR that included WGA below the
10th percentile or weight/length is likely to be a better measure
of FGR than WGA alone as it takes into account those babies
who are of acceptable weight but are disproportionately thin for
their length. Compared to WGA alone, this definition gave
higher PPVs at all BLWR thresholds. From a clinical perspect-
ive, over all gestational ages a BLWR of 5.0 or above correctly
predicted the presence of FGR in 100% of cases and a BLWR of
less than 5.0 correctly predicted the absence of FGR in 79% of
cases. Likewise, a BLWR of 4.0 or above correctly predicted
the presence of FGR in 74% of cases, and the absence of FGR in
81% of cases. A BLWR threshold of 3.3 optimised the classi-
fication: 52% of cases at or above this threshold were correctly
classified as FGR (PPV), while 84% of cases below this
threshold were correctly classified as non-FGR (NPV). A
higher BLWR was more likely to be predictive of FGR at
28-plus weeks gestation compared to more preterm babies;
a BLWR threshold of 3.7 was optimal for babies less than
28 weeks gestation and 3.0 for babies of 28-plus weeks
gestation.
Table 3 Number of classiﬁed true or false, positive or negative FGR cases for various BLWR thresholds by gestational age*
Group
FGR{ FGR based on BLWR
No Yes Ratio No Yes FP FN TP TN
All ages 266 90 2.8 195 161 103 32 58 163
3.0 230 126 72 36 54 194
3.5 285 71 31 50 40 235
4.0 317 39 10 61 29 256
4.5 333 23 3 70 20 263
5.0 338 18 0 72 18 266
3.3z 267 89 43 44 46 223
<28 weeks 153 28 2.8 100 81 64 11 17 89
3.0 117 64 47 11 17 106
3.5 145 36 20 12 16 133
4.0 161 20 7 15 13 146
4.5 170 11 2 19 9 151
5.0 173 8 0 20 8 153
3.7z 151 30 14 12 16 139
28 weeks 113 62 2.8 95 80 39 21 41 74
3.0 113 62 25 25 37 88
3.5 140 35 11 38 24 102
4.0 156 19 3 46 16 110
4.5 163 12 1 51 11 112
5.0 165 10 0 52 10 113
3.0z 113 62 25 25 37 88
BLWR, brain to liver weight ratio; FGR, fetal growth restriction; FN, false negative; FP, false positive; TN, true negative; TP, true positive.
* Excludes central nervous system conditions or chromosomal anomalies.
{Deﬁned using weight for gestational age <10th percentile or discordant birth weight/length.
zOptimal BLWR threshold for classifying FGR based on Youden’s index.
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This is the largest study published to date investigating the use
of the BLWR for determining FGR in a normative population of
perinatal deaths. Anderson investigated BLWR for determining
FGRusing 95 cases in a similar population,whileMitchell used a
population of 182 stillbirths.11,12 Stillborn babies who died
before the onset of labour were excluded from our study popu-
lation, addressing any potential confounding associated with
maceration following intra-uterine death or uncertain gestational
age at death. Further, the exclusion of congenital conditions of
the CNS or CA from the study population addresses any sub-
stantial confounding of congenital conditionswith brain and liver
growth. The addition of weight/length discordance to the FGR
definition of WGA below the 10th percentile substantially
improved the classification of babies greater than 28 weeks
gestation. This is consistent with an expected improved ascer-
tainment of Type II and Type III FGR, which both occur later in
pregnancy when most fetal growth occurs.
The strong biological evidence underpinning the ‘brain
sparing effect’ which leads to elevated BLWR13 suggests that,
in the absence of congenital anomalies that alter brain and liver
size, most cases of higher than normal BLWR are likely to
represent some sort of FGR/malnutrition.23 However, there is
currently no recognised single or definite method of ascertain-
ing whether an individual fetus truly has FGR or not. We used
WGA and weight/length discordance as the standard for FGR
diagnosis. These measures are based on population norms that
may fail to capture true FGR cases that meet percentile
thresholds while incorrectly flagging constitutionally small
but normal infants as FGR. The use of customised growth
charts that adjust for maternal characteristics such as height,
weight, parity and ethnic group, has been proposed as a way to
potentially enhance diagnosis of FGR,24 although the utility
and benefits of customised growth chart standards remain
uncertain.25 Diagnosis of FGR may also be informed by other
clinical information such as serial ultrasound measurements,
arterial umbilical blood flow, amniotic fluid index, other body
ratios such as head circumference to abdominal circumference
and femur length to abdominal circumference, and placental
markers of FGR, which were not available for this study. Others
combine the above parameters with more clinically and, to
some extent, experience based features such as thigh wasting,
generalised decrease in subcutaneous body fat and the baby
who clinically looks wasted. BLWR failed to show an associ-
ation with FGR in the subset of infants with congenital con-
ditions of the CNS or CA, and indicates that the BLWR is not
useful in the presence of conditions that impact the develop-
ment of the brain and/or the liver. While BLWR is not a perfect
measure of FGR, it would be of diagnostic value where the
gestation and/or the date of death are uncertain in the absence of
conditions affecting brain and/or liver weights.
Maroun and Graem10 examined the effect of maceration on
external measures including body weight and length as well as
on internal organs and found no statistically significant differ-
ence in body weight between the non-macerated babies and
those with various degrees of maceration. It was thought this
was possibly due to retention of fluid from organs into body
cavities. The finding of effusions is not uncommon in fetuses
with varying degrees of maceration. The birth weight is the best
indicator of the real body weight as once the fetus has been
handled and wrapped, the presence of skin blistering or skin
loss may result in significant fluid loss into the wrapping or
clothing. The study by Maroun and Graem also analysed organ
weights associated with various degrees of maceration. They
found that brain weight and, to a slightly lesser extent, heart
weight was only slightly affected by varying degrees of
maceration, though this is dependent on autopsy technique
in removal of brain. The liver, thymus and spleen weights
were the most severely affected. The BLWR was on average
2.6 in the non-macerated fetuses, correlating relatively well
with our figures, and 4.5 in the severely macerated fetuses
comprising those who had been dead in utero for approximately
4 weeks. This is an extraordinarily long period of time com-
pared with usual practice in our population, with antenatal visits
usually occurring 4 weeks apart or less in later pregnancy.
Furthermore, mothers are often aware of the significance of loss
or decrease of fetal movements, tending to report loss or
decrease in movements within 24–48 h, particularly in the
latter half of the third trimester.
Weight loss of organs such as the liver in maceration will
confound the use of the BLWR as a definitive marker of FGR in
maceration. However, BLWR could be used judiciously by
comparing organ weights with normal values and making an
assessment of the degree of maceration and organ weight loss
and therefore the significance of the BLWR. Our figure of 5.0
as the BLWR threshold to define all FGR, although missing the
detection of some cases, may be a suggestive indicator as to
when FGR should be considered in maceration. Diagnosis
should not be made without supporting data such as serial
ultrasound or flow studies, WGA less than 10th percentile, loss
of subcutaneous fat or other suggestive factors including details
on perceived degree of maceration and comparison with other
organ weights. Discordance between birth weight and length
may be used in maceration. Maroun and Graem10 found a small
but statistically significant increase in length in the macerated
group, which may be a true factor assuming all measurements
were done appropriately. We have found that in non-macerated
fetuses there is a tendency for measurements to be made
without straightening legs appropriately to obtain a true length,
possibly partially due to post-mortem rigidity which is not
present in the macerated fetus where joints are lax allowing
easier measurement of length.
In conclusion, we found that an elevated BLWR is associated
with FGR in the absence of congenital CNS conditions or CA,
and this association is stronger for babies greater than 28 weeks
gestation than more preterm babies. However, the association is
not perfect. A BLWR threshold of 5.0 was 100% predictive of
FGR, but was associated with a substantial number of missed
cases. A BLWR threshold of 3.3 optimised detection of true
cases while minimising the number of missed and false positive
cases. Optimal thresholds for babies less than and equal to or
greater than 28 weeks gestation were 3.7 and 3.0, respectively,
and use of these improved the overall performance of BLWR in
correctly classifying FGR. The BLWR is a suitable alternative
to WGA for diagnosing FGR in circumstances where the
weight or gestational age is uncertain and the baby is not
affected by CNS conditions or CA. This may include stillborn
babies who die before the onset of labour where the liver and
brain are not macerated or using multiple factors as discussed
above in the hands of an experienced perinatal pathologist.
Additional evidence should be sought to make a diagnosis of
FGR at a BLWR of less than 5.0 in all cases, as true cases of
FGR may be missed below this threshold.
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